Datexim
PrivateLast Round
VC Round
Oct 1, 2020
Total Funding Raised
$1.68M
Company Overview
Datexim is a healthcare technology company that develops AI-powered digital pathology solutions for cervical cancer screening and diagnostic workflow optimization.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Datexim Comparables
Compare Datexim with similar companies based on industry and business-model similarity.
Datexim Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Datexim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Odyssée Venture | Series A, VC Round |
| Normandie Participations | Series A, Seed |
| Bpifrance | Seed |
| Normandie Business Angels | Seed |
| Région Normandie | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors grew 88% MoM, from 631 to 1.2K.
- Oct 1, 2020
$1.18M round led by Odyssée Venture
Datexim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Datexim's valuation, stock price, and market status.
Is Datexim a public or private company?
Datexim is a private company.
What is the current stock price of Datexim?
Datexim is a private company, so its shares have no public market price. Caplight tracks Datexim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Datexim worth (valuation)?
Valuation information for Datexim is not publicly available.
Can I buy Datexim stock?
Datexim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Datexim's last funding round?
Datexim's most recent funding round was VC Round on October 1, 2020.
Who are the main investors in Datexim?
Key investors in Datexim include Odyssée Venture.
Will Datexim IPO soon?
No public IPO plans have been announced for Datexim.
How can I track Datexim secondary market activity?
Caplight tracks bids, offers, and trades in Datexim's shares on secondary markets.